Utility of peripheral blood dual color, double fusion fluorescent in situ hybridization for BCR/ABL fusion to assess cytogenetic remission status in chronic myeloid …
AP Landstrom, RP Ketterling, RA Knudson… - Leukemia & …, 2006 - Taylor & Francis
The molecular signature of BCR-ABL fusion in chronic myeloid leukemia (CML) provides a
unique tool for diagnosis and monitoring of tumor burden during therapy. The gold standard …
unique tool for diagnosis and monitoring of tumor burden during therapy. The gold standard …
[PDF][PDF] Utility of peripheral blood dual color, double fusion fluorescent in situ hybridization for BCR/ABL fusion to assess cytogenetic remission status in chronic myeloid …
A TEFFERI - Leukemia & Lymphoma, 2006 - researchgate.net
The molecular signature of BCR-ABL fusion in chronic myeloid leukemia (CML) provides a
unique tool for diagnosis and monitoring of tumor burden during therapy. The gold standard …
unique tool for diagnosis and monitoring of tumor burden during therapy. The gold standard …
Utility of peripheral blood dual color, double fusion fluorescent in situ hybridization for BCR/ABL fusion to assess cytogenetic remission status in chronic myeloid …
AP Landstrom, RP Ketterling… - Leukemia and …, 2006 - mayoclinic.elsevierpure.com
The molecular signature of BCR-ABL fusion in chronic myeloid leukemia (CML) provides a
unique tool for diagnosis and monitoring of tumor burden during therapy. The gold standard …
unique tool for diagnosis and monitoring of tumor burden during therapy. The gold standard …
Utility of peripheral blood dual color, double fusion fluorescent in situ hybridization for BCR/ABL fusion to assess cytogenetic remission status in chronic myeloid …
AP Landstrom, RP Ketterling… - Leukemia & …, 2006 - search.ebscohost.com
The molecular signature of BCR-ABL fusion in chronic myeloid leukemia (CML) provides a
unique tool for diagnosis and monitoring of tumor burden during therapy. The gold standard …
unique tool for diagnosis and monitoring of tumor burden during therapy. The gold standard …
Utility of peripheral blood dual color, double fusion fluorescent in situ hybridization for BCR/ABL fusion to assess cytogenetic remission status in chronic myeloid …
AP Landstrom, RP Ketterling, RA Knudson… - Leukemia & …, 2006 - europepmc.org
The molecular signature of BCR-ABL fusion in chronic myeloid leukemia (CML) provides a
unique tool for diagnosis and monitoring of tumor burden during therapy. The gold standard …
unique tool for diagnosis and monitoring of tumor burden during therapy. The gold standard …
Utility of peripheral blood dual color, double fusion fluorescent in situ hybridization for BCR/ABL fusion to assess cytogenetic remission status in chronic myeloid …
AP Landstrom, RP Ketterling… - Leukemia & …, 2006 - pubmed.ncbi.nlm.nih.gov
The molecular signature of BCR-ABL fusion in chronic myeloid leukemia (CML) provides a
unique tool for diagnosis and monitoring of tumor burden during therapy. The gold standard …
unique tool for diagnosis and monitoring of tumor burden during therapy. The gold standard …